This article needs additional citations for verification. (July 2008) |
Clinical data | |
---|---|
Trade names | Biocine, Lincocin |
AHFS/Drugs.com | Monograph |
MedlinePlus | a609005 |
Routes of administration | IM/IV |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | N/A |
Elimination half-life | 5.4 ± 1.0 h after IM or IV administration |
Excretion | Kidney and bile duct |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.296 |
Chemical and physical data | |
Formula | C18H34N2O6S |
Molar mass | 406.54 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Lincomycin is a lincosamide antibiotic that comes from the actinomycete Streptomyces lincolnensis.[3] A related compound, clindamycin, is derived from lincomycin by using thionyl chloride to replace the 7-hydroxy group with a chlorine atom with inversion of chirality.[4] It was released for medical use in September 1964.[5]